+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Hyaluronic Acid Fillers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update - Product Thumbnail Image

Hyaluronic Acid Fillers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • Report
  • March 2024
  • 115 Pages
  • Global
From
Ankylosing Spondylitis (Bekhterev's Disease) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Ankylosing Spondylitis (Bekhterev's Disease) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • January 2024
  • 595 Pages
  • Global
From
Major Depressive Disorder - Eight-Market Drug Forecast and Market Analysis - Update - Product Thumbnail Image

Major Depressive Disorder - Eight-Market Drug Forecast and Market Analysis - Update

  • Report
  • December 2023
  • 117 Pages
  • Global
From
Age-Related Macular Degeneration - Seven-Market Drug Forecast and Market Analysis - Update - Product Thumbnail Image

Age-Related Macular Degeneration - Seven-Market Drug Forecast and Market Analysis - Update

  • Report
  • December 2023
  • 115 Pages
  • Global
From
Gout - Opportunity Assessment and Forecast - Product Thumbnail Image

Gout - Opportunity Assessment and Forecast

  • Report
  • December 2023
  • 62 Pages
  • Global
From
Rheumatoid Arthritis (RA) - Competitive Landscape - Product Thumbnail Image

Rheumatoid Arthritis (RA) - Competitive Landscape

  • Report
  • December 2023
  • 91 Pages
  • Global
From
Oral Mucositis - Global Clinical Trials Review, 2023 - Product Thumbnail Image

Oral Mucositis - Global Clinical Trials Review, 2023

  • Clinical Trials
  • December 2023
  • 299 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease (COPD) - Global Clinical Trials Review, 2023 - Product Thumbnail Image

Chronic Obstructive Pulmonary Disease (COPD) - Global Clinical Trials Review, 2023

  • Clinical Trials
  • December 2023
  • 2092 Pages
  • Global
From
Insomnia - Opportunity Assessment and Forecast - Product Thumbnail Image

Insomnia - Opportunity Assessment and Forecast

  • Report
  • December 2023
  • 67 Pages
  • Global
From
Gaucher Disease - Opportunity Assessment and Forecast - Product Thumbnail Image

Gaucher Disease - Opportunity Assessment and Forecast

  • Report
  • December 2023
  • 59 Pages
  • Global
From
Generalized Pustular Psoriasis (GPP) - Competitive Landscape - Product Thumbnail Image

Generalized Pustular Psoriasis (GPP) - Competitive Landscape

  • Report
  • December 2023
  • 78 Pages
  • Global
From
Bacterial Vaginosis (BV) - Competitive Landscape - Product Thumbnail Image

Bacterial Vaginosis (BV) - Competitive Landscape

  • Report
  • December 2023
  • 75 Pages
  • Global
From
Structural Heart Occluders Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies - Product Thumbnail Image

Structural Heart Occluders Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

  • Report
  • November 2023
  • 104 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) Infections Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) Infections Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  • Report
  • November 2023
  • 270 Pages
  • Global
From
Plaque Psoriasis (Psoriasis Vulgaris) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update - Product Thumbnail Image

Plaque Psoriasis (Psoriasis Vulgaris) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  • Report
  • November 2023
  • 1203 Pages
  • Global
From
Down Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update - Product Thumbnail Image

Down Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  • Report
  • November 2023
  • 100 Pages
  • Global
From
Myasthenia Gravis Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032 - Product Thumbnail Image

Myasthenia Gravis Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032

  • Report
  • October 2023
  • 68 Pages
  • Global
From
Lennox-Gastaut Syndrome (LGS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Lennox-Gastaut Syndrome (LGS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • October 2023
  • 74 Pages
  • Global
From
Metachromatic Leukodystrophy (MLD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Metachromatic Leukodystrophy (MLD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • October 2023
  • 65 Pages
  • Global
From
Acute Renal Failure (ARF) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Acute Renal Failure (ARF) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • October 2023
  • 68 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more